Pathway Genomics' Insight test will be on the shelves of about 6,000 Walgreens, reports the Washington Post. This "boldest move yet to bring the power of modern molecular medicine to the mass market" may also me "irresponsible" as it "could give many buyers a dangerous false sense of security or, conversely, needlessly alarm them," the Post says.